Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trial

202364 citationsJournal Articlehybrid Open Access

Authors

National Institute for Health and Care Research.

Good health and well-being

Published in: The Lancet Respiratory Medicine

Volume 12, Issue 1, pp. 67-77

Field-Weighted Citation Impact: 16.47